EP3768322 - FORMULATION [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 27.06.2024 Database last updated on 14.11.2024 | |
Former | Grant of patent is intended Status updated on 21.02.2024 | ||
Former | Examination is in progress Status updated on 24.02.2023 | ||
Former | Request for examination was made Status updated on 25.12.2020 | ||
Former | The international publication has been made Status updated on 28.09.2019 | ||
Former | unknown Status updated on 06.05.2019 | Most recent event Tooltip | 27.06.2024 | (Expected) grant | published on 31.07.2024 [2024/31] | Applicant(s) | For all designated states GREEN PARK PHARMA UK LTD 6 Chi An Lorell Aerohub Business Park St Mawgan Newquay, Cornwall TR8 4JZ / GB | [2024/31] |
Former [2024/30] | For all designated states GREEN PARK PHARMA UK LTD 6 Chi An Lorell Aerohub Business Park St Mawgan Newquay, Cornwall TR8 4JZ / GB | ||
Former [2023/45] | For all designated states Avida Medical Limited Genesis House Merrow Lane Guildford GU4 7BN / GB | ||
Former [2021/04] | For all designated states BCM Specials Limited 1 Thane Road West Nottingham Nottinghamshire NG2 3AA / GB | Inventor(s) | 01 /
SHERRY, Robert Arthur 18 Raeburn Drive Toton Nottingham Nottinghamshire NG9 6LF / GB | 02 /
TANG, Weng Sam BCM Specials Limited 1 Thane Road West Nottingham Nottinghamshire NG2 3AA / GB | 03 /
BARFIELD, John Gerard BCM Specials Limited 1 Thane Road West Nottingham Nottinghamshire NG2 3AA / GB | [2021/04] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2024/31] |
Former [2021/04] | Adamson Jones BioCity Nottingham Pennyfoot Street Nottingham NG1 1GF / GB | Application number, filing date | 19719587.8 | 22.03.2019 | [2021/04] | WO2019GB50823 | Priority number, date | GB20180004621 | 22.03.2018 Original published format: GB 201804621 | [2021/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019180456 | Date: | 26.09.2019 | Language: | EN | [2019/39] | Type: | A1 Application with search report | No.: | EP3768322 | Date: | 27.01.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.09.2019 takes the place of the publication of the European patent application. | [2021/04] | Type: | B1 Patent specification | No.: | EP3768322 | Date: | 31.07.2024 | Language: | EN | [2024/31] | Search report(s) | International search report - published on: | EP | 26.09.2019 | Classification | IPC: | A61K47/14, A61K9/00, A61K9/14, A61K9/16, A61K31/4439 | [2021/04] | CPC: |
A61K9/0095 (EP);
A61K31/4439 (EP,US);
A61K47/14 (EP,US);
A61K47/44 (US);
A61K9/0053 (US);
A61K9/145 (EP);
A61K9/1617 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/04] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | FORMULIERUNG | [2021/04] | English: | FORMULATION | [2021/04] | French: | FORMULATION | [2021/04] | Entry into regional phase | 16.10.2020 | National basic fee paid | 16.10.2020 | Designation fee(s) paid | 16.10.2020 | Examination fee paid | Examination procedure | 16.10.2020 | Examination requested [2021/04] | 16.10.2020 | Date on which the examining division has become responsible | 07.05.2021 | Amendment by applicant (claims and/or description) | 28.02.2023 | Despatch of a communication from the examining division (Time limit: M06) | 11.09.2023 | Reply to a communication from the examining division | 22.02.2024 | Communication of intention to grant the patent | 24.06.2024 | Fee for grant paid | 24.06.2024 | Fee for publishing/printing paid | 24.06.2024 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 19.03.2021 | Renewal fee patent year 03 | 19.01.2022 | Renewal fee patent year 04 | 17.01.2023 | Renewal fee patent year 05 | 18.01.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XDI]EP0273890 (ASTRA LAEKEMEDEL AB [SE]); | [I]JP2007161694 (ORIENTAL PHARM SYNTH CHEM); | [I]US2013115294 (FIRST SIGAL [IL]); |